Internal Medicine, Nephrology · Upland, CA
NPI
1740424712
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1317 W Foothill Blvd, Ste 148
Upland, CA, 91786
Phone (909) 981-5882
Groups this clinician bills Medicare through
Medicare paid, 2024
$298K
4,551 services
Medicare patients, 2024
444
Average age 72
Drug cost, 2024
$898K
3,126 prescriptions
Company payments, 2025
$39.14
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nima Naimi was code 99233 (hospital e&m - subsequent), 810 times for 200 patients. In total Nima Naimi billed 4,551 services in 20 codes, and Medicare paid $298K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 810 | 200 | $85.88 | $70K |
| 99458 E&M - Miscellaneous | Office | 784 | 46 | $29.23 | $23K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 564 | 36 | $35.03 | $20K |
| 99457 E&M - Miscellaneous | Office | 373 | 55 | $36.45 | $14K |
| 99454 E&M - Miscellaneous | Office | 350 | 43 | $36.43 | $13K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 323 | 35 | $31.99 | $10K |
| 90960 ESRD Related Services (not dialysis) | Office | 319 | 43 | $256.05 | $82K |
| 99214 Office E&M - Established | Office | 296 | 159 | $71.18 | $21K |
| 99223 Hospital E&M - Initial | Facility | 134 | 123 | $125.69 | $17K |
| 90961 ESRD Related Services (not dialysis) | Office | 31 | 13 | $213.36 | $6,614 |
| 99204 Office E&M - New | Office | 27 | 27 | $123.89 | $3,345 |
| 99453 E&M - Miscellaneous | Office | 16 | 16 | $15.43 | $247 |
By year: 2022 $289K for 3,956 services; 2023 $302K for 4,563 services; 2024 $298K for 4,551 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nima Naimi prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 322 prescriptions and refills. In total Nima Naimi wrote 3,126 Medicare prescriptions that cost $898K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 322 | 528 | 80 | $282K |
| Amlodipine Besylate Generic | 244 | 648 | 85 | $1,358 |
| Losartan Potassium Generic | 183 | 497 | 63 | $1,522 |
| Atorvastatin Calcium Generic | 173 | 449 | 60 | $1,557 |
| Prosol Parenteral Amino Acid 20% No.1 | 163 | 163 | Under 11 | $27K |
| Furosemide Generic | 137 | 364 | 56 | $785 |
| Ozempic Semaglutide | 85 | 113 | 26 | $94K |
| Dapagliflozin Dapagliflozin Propanediol | 78 | 110 | 23 | $51K |
| Famotidine Generic | 76 | 186 | 24 | $674 |
| Chlorthalidone Generic | 75 | 191 | 26 | $1,383 |
| Hydrochlorothiazide Generic | 73 | 186 | 24 | $220 |
| Spironolactone Generic | 70 | 164 | 21 | $773 |
| Sevelamer Carbonate Generic | 64 | 139 | 31 | $19K |
| Hydralazine Hcl Generic | 59 | 141 | 23 | $1,050 |
| Tamsulosin Hcl Generic | 58 | 123 | 17 | $520 |
Brand drugs: - claims; generic drugs: 2,235 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nima Naimi $39.14 ($39.14 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $20.14.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.14 |
| Novo Nordisk Inc NVO | 1 | $19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.